Details for Patent: 11,351,182
✉ Email this page to a colleague
Which drugs does patent 11,351,182 protect, and when does it expire?
Patent 11,351,182 protects IMVEXXY and is included in one NDA.
This patent has one hundred and sixty patent family members in twenty-one countries.
Summary for Patent: 11,351,182
Title: | Vaginal inserted estradiol pharmaceutical compositions and methods |
Abstract: | According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy. |
Inventor(s): | Bernick; Brian A. (Boca Raton, FL), Thorsteinsson; Thorsteinn (Boynton Beach, FL), Persicaner; Peter H. R. (Boca Raton, FL), Cacace; Janice Louise (St. Petersburg, FL), Sancilio; Frederick D. (Stuart, FL), Irani; Neda (Palm Beach Gardens, FL), Amadio; Julia (Boca Raton, FL) |
Assignee: | TherapeuticsMD, Inc. (Boca Raton, FL) |
Application Number: | 16/833,186 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 11,351,182
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-001 | May 29, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF DYSPAREUNIA | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-001 | May 29, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-002 | May 29, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF DYSPAREUNIA | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-002 | May 29, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,351,182
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2782584 | ⤷ Sign Up | 301153 | Netherlands | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | 2021C/558 | Belgium | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | 122021000080 | Germany | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | LUC00245 | Luxembourg | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |